New Novartis R&D centre in China
Fabrice Martin
Swiss pharmaceutical lab company Novartis announced its 8th R&D centre in Shanghaï, China.Mainly dedicated to research on infectious causes of prevalent cancers in China, this centre represents a USD 100 million investment. By establishing its new centre, which should employ more than 400 researchers by 2008, at the Zhangjiang Hi-Tech Park, near Shanghaï, Novartis bets on the development of this emerging life science cluster.
Operations are set to begin in May 2007.
More information about ABG?
Get ABG’s monthly newsletters including news, job offers, grants & fellowships and a selection of relevant events…
Discover our members
ADEME
Tecknowmetrix
Groupe AFNOR - Association française de normalisation
Aérocentre, Pôle d'excellence régional
TotalEnergies
Nokia Bell Labs France
ONERA - The French Aerospace Lab
MabDesign
PhDOOC
SUEZ
ANRT
CESI
Généthon
MabDesign
CASDEN
Laboratoire National de Métrologie et d'Essais - LNE
Institut de Radioprotection et de Sureté Nucléaire - IRSN - Siège
Institut Sup'biotech de Paris
Ifremer
-
JobPermanentRef. ABG124941Corteria Pharmaceuticals- Ile-de-France - France
Jeune Docteur, Chercheur en Biologie Cellulaire & Moléculaire (H/F)
BiologyAny -
JobPermanentRef. ABG123642Laboratoire des Courses Hippiques (GIE LCH)- Ile-de-France - France
Chargé(e) de Recherche et Innovation (H/F) / Senior Scientist Research & Innovation (M/F)
Chemistry - BiochemistryConfirmed -
JobFixed-termRef. ABG125071KTH- Sweden
ERC-funded postdoc position on the detection of gas-phase organic radicals, KTH, Stockholm, Sweden
Chemistry - Physics - Engineering sciencesAny